Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;32(2):227-234.
doi: 10.1002/mds.26839. Epub 2016 Oct 25.

Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study

Affiliations

Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study

Rodolfo Savica et al. Mov Disord. 2017 Feb.

Abstract

Background: Epidemiological studies of drug-induced parkinsonism remain limited.

Objectives: To investigate the incidence and time trends of drug-induced parkinsonism over 30 years in a geographically defined American population.

Methods: We used the medical records-linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug-induced parkinsonism associated with dopamine-blocking or dopamine-depleting medications.

Results: Among 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug-induced parkinsonism (11.9%). The average annual incidence rate of drug-induced parkinsonism was 3.3 per 100,000 person-years, was higher in women, and increased with older age. Drug-induced parkinsonism was the fifth-most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug-induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49-0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women.

Conclusions: The incidence of drug-induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug-induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Keywords: drug-induced parkinsonism; incidence; parkinsonism; sex differences; time trends.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Average annual age‐ and sex‐specific incidence rates for the 30‐year period from 1976 to 2005 in men and women separately for all types of parkinsonism (left panel) and drug‐induced parkinsonism (right panel). The y‐axis scale is different in the two panels.
Figure 2
Figure 2
Incidence rate curves across calendar years for men and women estimated using single‐year data points and negative binomial regression for all types of parkinsonism (left panel) and drug‐induced parkinsonism (right panel). The y‐axis scale is different in the two panels. RR refers to the average change over 10 years.
Figure 3
Figure 3
Distribution of incident cases of drug‐induced parkinsonism by decade of study and primary indication for treatment in men and women separately.

Comment in

Similar articles

Cited by

References

    1. Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau. Intern Med J 2006;36:652–660. - PubMed
    1. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease‐related pathology. Cell Tissue Res 2004;318:121–134. - PubMed
    1. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 2013;70:859–866. - PMC - PubMed
    1. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009;85:322–326. - PubMed
    1. Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med 2005;165:1882–1888. - PubMed

Publication types

Substances